» Authors » Sylvain Marchand-Adam

Sylvain Marchand-Adam

Explore the profile of Sylvain Marchand-Adam including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 119
Citations 2494
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Le Brun M, Nathan N, Louvrier C, Legendre M, Feuillet S, Frija-Masson J, et al.
ERJ Open Res . 2025 Mar; 11(2). PMID: 40040902
https://bit.ly/3TMWKK9.
2.
Ferreira M, Bejan-Angoulvant T, Marchand-Adam S, Mousset E, Mureau E, Jouneau S, et al.
Respir Med Res . 2024 Dec; 87:101144. PMID: 39693827
Introduction: Progressive interstitial lung diseases (ILDs) are rare but severe diseases, with high mortality and morbidity, with no effective pharmacological treatment allowing for long-term remission, and therefore no clear therapeutic...
3.
Lalmanach G, Rigoux B, David A, Tahri-Joutey M, Lecaille F, Marchand-Adam S, et al.
Clin Chim Acta . 2024 Oct; 565:120016. PMID: 39461496
Human cystatin C (hCC), which has a pervasive distribution within body fluids and is ubiquitously expressed by numerous cells and tissues, is a highly potent extracellular inhibitor of cysteine proteases....
4.
Mansy L, Caille A, Reynaud-Gaubert M, Bermudez J, Bonniaud P, Borie R, et al.
Eur Respir J . 2024 Sep; 64(3. PMID: 39231630
No abstract available.
5.
Xu Y, Ternant D, Reynaud-Gaubert M, Bejan-Angoulvant T, Marchand-Adam S
Fundam Clin Pharmacol . 2024 Jun; 38(5):1008-1016. PMID: 38880975
Background: Mycophenolate mofetil (MMF) has been used to treat interstitial lung disease (ILD), but mycophenolate (MPA) pharmacokinetics was not reported for this use. This ancillary study of the EVER-ILD protocol...
6.
Mercier C, Thoreau B, Flament T, Legue S, Pearson A, Jobard S, et al.
J Clin Med . 2024 May; 13(10). PMID: 38792426
High-resolution computed tomography (HRCT) may lack sensitivity for the early detection of interstitial lung disease associated with systemic sclerosis (SSc-ILD). Lung ultrasound is an emerging technique for the diagnosis of...
7.
Brudon A, Legendre M, Mageau A, Bermudez J, Bonniaud P, Bouvry D, et al.
Eur Respir J . 2024 Apr; 63(5). PMID: 38575158
Background: Several rare surfactant-related gene (SRG) variants associated with interstitial lung disease are suspected to be associated with lung cancer, but data are missing. We aimed to study the epidemiology...
8.
Godet C, Brun A, Couturaud F, Laurent F, Frat J, Marchand-Adam S, et al.
Chest . 2024 Feb; 165(6):1307-1318. PMID: 38387646
Background: One of the major challenges in managing allergic bronchopulmonary aspergillosis remains consistent and reproducible assessment of response to treatment. Research Question: What are the most relevant changes in CT...
9.
Diesler R, Legendre M, Si-Mohamed S, Brillet P, Wemeau L, Manali E, et al.
Respirology . 2024 Feb; 29(4):312-323. PMID: 38345107
Background And Objective: Variants in surfactant genes SFTPC or ABCA3 are responsible for interstitial lung disease (ILD) in children and adults, with few studies in adults. Methods: We conducted a...
10.
Chevereau-Choquet M, Thoreau B, Taille C, Marchand-Adam S, Morel H, Plantier L, et al.
J Asthma Allergy . 2024 Feb; 17:69-79. PMID: 38318088
Purpose: Severe asthma affects 5 to 10% of asthmatics and accounts for a large part of asthma-related morbidity and costs. The determinants of asthma severity are poorly understood. We tested...